English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Dec 18, 2024

EPA approves California's advanced clean cars policy amid push for cleaner air
+ Pharmaceuticals
Patient Daily | Dec 18, 2024

American Lung Association partners with MCMS to tackle poor air quality impacts
+ Pharmaceuticals
Patient Daily | Dec 18, 2024

Annual stair-climbing event returns to Jacksonville for lung health awareness
+ Pharmaceuticals
Patient Daily | Dec 17, 2024

Arizona voters show strong support for clean energy transition
+ Pharmaceuticals
Patient Daily | Dec 17, 2024

Lung association warns against combined risks of smoking and radon
Patient Daily | Dec 16, 2024

Health Analysts: 340b drug program is 'a wasteful program that does not serve the low-income populations it was intended to serve'
+ Pharmaceuticals
Patient Daily | Dec 16, 2024

UTHealth Houston highlights achievements across innovation, research, community health
+ Pharmaceuticals
Patient Daily | Dec 16, 2024

Research unveils molecular changes leading to Rett syndrome

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones